P wave and QT changes among inpatients with schizophrenia after parenteral ziprasidone administration

Pharmacological Research

Volumn 60, Issue 5, 2009, Pages 369-372

  Emul, Murat ^a   Dalkiran, Mihriban ^b   Coskun, Orhan ^b   Yavuz, Ruhi ^b   Tosun, Musa ^b   Duran, Alaattin ^b   Ugur, Mufit ^b   Keles, Ibrahim ^b  

^a University Hospital of Afyon Kocatepe   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; P wave dispersion; QT dispersion; QTc; Ziprasidone

Indexed keywords

ZIPRASIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HOSPITAL PATIENT; HUMAN; MALE; P WAVE; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; SCHIZOPHRENIA; SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; SCHIZOPHRENIA; THIAZOLES;

EID: 69549116448     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.07.008     Document Type: Article

References (21)

1. Stollberger C., Huber J.O., and Finsterer J. Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol 20 5 (2005) 243-251
2. Haddad P.M., and Anderson I.M. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 62 (2002) 1649-1671
3. Simpson G.M., Glick I.D., Weiden P.J., Romano S.J., and Siu C.O. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Am J Psychiatry 161 (2004) 1837-1847
4. Ray W.A., Meredith S., Thapa P.B., Meador K.G., Hall K., and Murray K.T. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 58 (2001) 1161-1167
5. Reilly J.G., Ayis S.A., Ferrier I.N., Jones S.J., and Thomas S.H.L. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355 (2000) 1048-1052
6. Straus S.M., Bleumink G.S., Dieleman J.P., Van der Lei J., 't Jong G.W., Kingma J.H., et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 164 (2004) 1293-1297
7. Dogangun B., Guzeltas A., Emul M., Demir T., Karacetin G., Oztunç F., et al. Assessment of P wave dispersion in children treated with risperidone. Neurol Psychiatry Brain Res 14 (2007) 115-118
8. Bayar R., Emul M., Turan S., Zerdali H., Salihoglu T., Duran A., et al. Electrocardiographical P wave changes after electroconvulsive therapy in patients with schizophrenia: a preliminary study. J ECT 25 1 (2009) 26-30
9. Dilaveris P.E., Gialofos E.J., Andrikopoulos G.K., Richter D.J., Papanikolaou V., Poralis K., et al. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 23 (2000) 352-358
10. Aytemir K., Ozer N., Atalar E., Sade E., Aksoyek S., Ovunç K., et al. P-wave dispersion on 12-lead electrocardiogram in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23 (2000) 1109-1112
11. First M.B., Spitzer R.L., Gibbon M., and Williams JBW. Structured clinical interview for Axis I DSM-IV disorders-patient version (SCID-1/P version 2.0) (1996), New York State Psychiatric Institute Biometrics Research Department, New York
12. Kocer A., Karakaya O., Barutcu I., Esen O.B., Kargi{dotless}n R., and Domac M. Assesment of P wave duration and dispersion in Parkinson's disease. Prog NeuroPsychopharmacol Biol Psychiatry 30 4 (2006) 718-723
13. Preskorn S.H. Pharmacokinetics and therapeutics of acute intramuscular ziprasidone. Clin Pharmacokinet 44 11 (2005) 1117-1133
14. Overall J.E., and Gorham D.R. The brief psychiatric rating scale. Psychol Rep 10 (1962) 799-812
15. Andreasen N.C. Scale for the assessment of negative symptoms (SANS) (1984), University of Iowa, Iowa City
16. Andreasen N.C. Scale for the assessment of positive symptoms (SAPS) (1984), University of Iowa, Iowa City
17. Dilaveris P.E., and Gialofos J.E. P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 6 (2001) 159-165
18. Flaker G.C., Fletcher K.A., Rothbart R.M., Halperin J.L., and Hart R.G. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) investigators. Am J Cardiol 76 (1995) 355-358
19. Aytemir K., Hnatkova K., and Malik M. Duration of the P wave dispersion in normal healthy population. Turk J Intervent Cardiol 3 (1999) 142-147
20. Seyfeli E., Duru M., Kuvandik G., Kaya H., and Yalcin F. Effect of obesity on P-wave dispersion and QT dispersion in women. Int J Obes (Lond) 30 6 (2006) 957-961
21. Bazett H.C. An analysis of time relations of electrocardiograms. Heart 7 (1920) 353-367